Project Details
| Acronym | GS-US-548-5916 |
|---|---|
| Status | Active |
| Effective start/end date | 3/08/21 → 29/07/26 |
A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma
- Park, John (Primary Chief Investigator)
- Sabanathan, Dhanusha (Associate Investigator)
- Xia, Cathy Yi (Associate Investigator)
- Kim, Sang (Associate Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research